| Literature DB >> 33456268 |
D B Nandini1, Roopa S Rao2, B S Deepak3, Praveen B Reddy4.
Abstract
Isothicyanates present in cruciferous vegetables are known to exhibit chemoprevention by various mechanisms. Presently, there is growing evidence that a phytochemical compound known as sulforaphane in these green leafy vegetables is found to be effective in preventing and treating various cancers such as prostate cancer, breast cancer, colon cancer, skin, urinary bladder and oral cancers. This component is naturally present in the broccoli sprouts, kale, cabbage, cauliflower and garden cress and is available as a commercial supplementary pill called Broccoli extract. Availability of many bioactive substances such as vitamins, polyphenols, sulfides, glucosinolates and antioxidants makes broccoli consumption important in daily diet regularly. Researchers have named it as "Green chemoprevention." It is easily affordable and more cost-effective than the traditional chemopreventive drugs. Results from the epidemiological and experimental studies have emphasized the role of sulforophane as a complementary or alternative chemopreventive agent. Copyright:Entities:
Keywords: Adjuvant therapy; anticarcinogenic; antioxidant; antitumor; apoptosis; benefits; broccoli; cell cycle; chemoprevention; effects; glucosinates; isothiocyanates; nutraceuticals myrosinase; sulforaphane
Year: 2020 PMID: 33456268 PMCID: PMC7802872 DOI: 10.4103/jomfp.JOMFP_126_19
Source DB: PubMed Journal: J Oral Maxillofac Pathol ISSN: 0973-029X
Anticancer effects of sulforaphane
| Anticancer effects | Action of SFN |
|---|---|
| Induction of cell cycle arrest (S and G2/M) | Increases cyclin 2, chk 2, p21 |
| Reduction in cell proliferation | Inhibits Phase 1 enzymes such as the CYP p450 family |
| Induction in apoptosis | SFN induces pro-apoptotic pathway and inhibits anti-apoptotic pathways, |
| Inhibition of tumor invasion, angiogenesis and anti-inflammatory effect | Inhibits NF-κB pathway, activates Nrf-2 |
| Epigenetic modulation and altered gene expression through histone deacetylase inhibition, global demethylation and microRNA modulation | The Keap1/Nrf2 antioxidant pathway modulation |
| Antimicrobial effects | Increases human β defensins 2 |
| Antioxidant effects | Induction of the Keap1/Nrf2/ARE pathway related with antioxidant genes and detoxifying enzymes, such as glutathione S-transferases |
SFN: Sulforaphane, PARP: Poly (ADP-ribose) polymerase, HIF1A: Hypoxia-inducible factor 1A, NF-κB: Nuclear factor-kappa B, Nrf-2: Nuclear factor erythroid-2-related factor 2, MAPK: Mitogen-activated protein kinase, TNF-α: Tumor necrosis factor-alpha, IL: Interleukin, IFN-γ: Interferon-gamma, TGF-β: Transforming growth factor-β, NO: Nitric oxide, iNOS: Inducible NO synthase, COX: Cyclooxygenase, MMP: Matrix metalloproteinase, LDH: Lactate dehydrogenase, PGE2: Prostaglandin E2, ROS: Reactive oxygen species, VEGF: Vascular endothelial growth factor, EGF: Epidermal growth factor, CSF: Colony stimulating factor, HDAC: Histone deacetylases, miR: MicroRNA, hTERT: Human telomerase reverse transcriptase, DNMT: DNA methyltransferases, CYP: Cytochrome P450, NQO: Nitroquinoline-1-oxide, GSTA: Glutathione-s-transferase, NLRP3: Nucleotidebinding domain (NOD)-like receptor protein 3, YM: A macrophage protein, a novel mammalian lectin